About
LiquidCell Dx develops a comprehensive liquid biopsy platform that non-invasively profiles both tumors and their microenvironment from blood samples to improve cancer treatment prediction and monitoring.
Explore LiquidCell Dx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.